Sono-Tek 2026 Q3 Earnings Net Income Surges 24% Despite Revenue Decline

Wednesday, Jan 14, 2026 6:20 am ET1min read
SOTK--
Aime RobotAime Summary

- Sono-TekSOTK-- (SOTK) reported 24% higher Q3 2026 net income ($339,959) despite 3.6% revenue decline to $5M, driven by improved margins and cost discipline.

- Revenue drop attributed to weaker alternative energy demand and geopolitical shifts, partially offset by strong medical/electronics sector performance.

- EPS remained stable at $0.02, with CEO emphasizing high-ASP systems and $2.8M/5M medical coating orders boosting long-term growth confidence.

- Post-earnings trading strategyMSTR-- yielded -18.05% return, highlighting poor risk-adjusted performance despite six-year profitability streak.

Sono-Tek (SOTK) reported mixed Q3 2026 results, with revenue declining 3.6% year-over-year but net income rising 24%. The company maintained stable EPS at $0.02 and reiterated guidance for modest annual revenue growth.

Revenue

Sono-Tek’s total revenue fell to $5 million in Q3 2026, a 3.6% decrease from $5.19 million in the prior-year period. Fluxing Systems generated $222,000, while In-Line Coating Systems contributed $1.84 million. Multi-Axis Coating Systems accounted for $1.67 million, OEM Systems brought in $425,000, and Other segments totaled $847,000. The decline was attributed to reduced demand in the Alternative Energy segment and geopolitical policy shifts, partially offset by strong medical and electronics market performance.

Earnings/Net Income

The company’s profitability strengthened, with net income rising 24% to $339,959, driven by improved gross margins and operating leverage. EPS remained stable at $0.02, reflecting disciplined cost management. The sustained profitability for six consecutive years underscores operational resilience despite sector-specific headwinds.

Post-Earnings Price Action Review

A strategy of buying SOTKSOTK-- when earnings beat and selling after 30 days yielded a -18.05% return, underperforming the benchmark’s 52.59%. The approach avoided losses with a 0.00% maximum drawdown but delivered a negative Sharpe ratio of -0.08, indicating poor risk-adjusted returns. A 30-day holding period proved insufficient for price recovery, resulting in a -4.70% CAGR and 57.09% volatility.

CEO Commentary

Dr. Christopher Coccio, Executive Chairman, emphasized the success of prioritizing high-average-selling-price (ASP) production systems and maintaining cost discipline. Steve Harshbarger, CEO, highlighted sustained demand in medical and electronics sectors, offsetting alternative energy softness, and reiterated confidence in long-term growth driven by a strong backlog and strategic focus on high-ASP systems.

Guidance

Sono-Tek reiterated FY2026 guidance for modest revenue growth, balancing policy-driven market adjustments with expanding medical device demand.

Additional News

  1. $2.8M Medical Device Order: Sono-TekSOTK-- secured a $2.8 million order for advanced medical coating systems in October 2025, expanding its presence in high-value production.

  2. $5M Medical System Deal: A $5 million order for MediCoat systems in September 2025 underscored growing adoption in precision manufacturing.

  3. Conference Call Announcement: The company announced a Q2 2026 earnings call in October 2025, aligning with its strategy to enhance investor transparency.

Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet